SICHUAN YUANDA SHUYANG PHARMACEUTICAL CO.,LTD

About SICHUAN YUANDA SHUYANG PHARMACEUTICAL CO.,LTD

Sichuan Yuanda Shuyang Pharmaceutical Co Ltd (Shuyang) was founded in 1985 and now is a subsidiary of China Grand Enterprises, Inc.  The total asset of Shuyang is more than 1.5 billion Yuan, with 1.5 billion Yuan of annual sales revenue in 2018.  The company has 17 subsidiary plasmapheresis centers.  The products are selling all over the country and already entering into inte...

  • CN
  • 2015
    On CPHI since
Contact info
Meet us at

CPHI & PMEC China 2024

Shanghai New International Expo Center
19 - 21 June 2024

Products from SICHUAN YUANDA SHUYANG PHARMACEUTICAL CO.,LTD (3)

  • Human Albumin

    Product Human Albumin

    The main component of this preparation is human albumin, which is prepared by cold ethanol fractionation of human plasma from healthy donors. The manufacturing process of human albumin contains a step of heating the final solution at 60℃ for 10 hours to inactivate the viruses present in it. It contains...
  • Human Hepatitis B Immunoglobulin

    Product Human Hepatitis B Immunoglobulin

    The manufacturing process for human hepatitis B immunoglobulin contains a step of low pH incubation for viral inactivation. It contains a suitable amount of glycine as stabilizer, but does not contain any antiseptic or antibiotic.

    Indications:
    -Post-exposure prophylaxis should be c...
  • Human Hepstitis B Immunoglobulin (Ph4) For Intrevenous Injection

    Product Human Hepstitis B Immunoglobulin (Ph4) For Intrevenous Injection

    Major constituent: Human hepatitis B immunoglobulin; Subsidiary material: Maltose

    Indications:Use of the product in combination with lamivudine can prevent patients with HBV (hepatitis B virus)-related diseases from being re-infected with HBV after liver transplantation.

    Strengths:200...